Less than 10% of patients developing severe chemotherapy-induced anemia did not have any of the identified potential patient-related risk factors.
Researchers reviewed cancer incidence in patients with Diamond-Blackfan anemia.
Managing anemia in patients with myelodysplastic syndrome (MDS) is complex. When are erythroid growth factors used as primary treatment?
In following patients with anemia, what do the lab values for iron, ferritin, transferrin, and TIBC (total iron binding capacity) tell me?
Adding the ESA epoetin alfa to the chemotherapy regimen for high-risk breast cancer improved hemoglobin levels for patients, but it also resulted in increased thrombosis.
Chemotherapy-induced nerve injury in the bone marrow is what impairs the regeneration of hematopoietic stem cells, leading to anemia.
Abiraterone markedly prolongs survival in men with metastatic castration-resistant prostate cancer that has progressed after docetaxel therapy.
Cisplatin binds 20-fold more pervasively to RNA than to DNA, making RNA a potential new drug target for the platinum compound, which is used to fight tumors in nearly 70% of cancers.
Recent study results suggest that a targeted immunotherapy based on a poxvirus may make chemotherapy for advanced non-small cell lung cancer more effective and slow disease progression.
The recent discovery of gene mutations in a genomic study of myelodysplastic syndromes could enable diagnosis using only a blood test rather than a bone marrow biopsy.
